Factors associated with compliance to cervical cancer screening in France: The EDIFICE 6 survey

被引:2
|
作者
Rouge, Thibault de la Motte [1 ]
Touboul, Chantal [2 ]
Lhomel, Christine [3 ]
Roupret, Morgan [4 ]
Morere, Jean-Francois [5 ]
机构
[1] Ctr Eugene Marquis, Av Bataille Flandres Dunkerque CS 44229, F-35042 Rennes, France
[2] Kantar, Hlth Div, Paris, France
[3] Roche, Boulogne, France
[4] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Oncotype URO, GRC 5, F-75013 Paris, France
[5] Hop Paul Brousse, Villejuif, France
关键词
Uterine cervical neoplasms; Early detection of Cancer; Mass screening; Attitude to health; Socioeconomic factors; Risk factors; WOMEN; HPV;
D O I
10.1016/j.ygyno.2020.10.032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction. A nationwide cervical cancer (CC) screening program was implemented in France in 2018. Asymptomatic women are invited for a cytological test once every 3 years (age, 25-29 years), and an HPV test every 5 years (age, 30-65 years). We investigated the characteristics of women who are resistant to CC screening. Methods. Since 2005, the EDIFICE survey program has assessed attitudes toward cancer screening in France. The 6th edition (2017) included 12,046 representative women (age, 18-69 years). Social vulnerability was assessed using the EPICES score. Multivariate stepwise logistic regression analysis identified factors correlated with nonuptake of CC screening. Results. Questionnaires from 4499 women (age, 25-65 years) with no history of cancer were analyzed: 88% (N = 3960) reported at least one test in their lifetime, and 73% (N = 3262) did the test in the previous 3 years. Compared to ever-screened women, never-screened women were younger (38 +/- 11 yrs. vs 44 +/- 12 yrs., P < 0.05), and more likely to be single (48% vs 20%, P < 0.05) and/or socially vulnerable (59% vs 38%, P < 0.05). In multivariate analysis, items significantly (P <0.05) associated with never screening included living alone (OR - 226, 95% a [1.85-2.75]) and social vulnerability (OR - 1.95 [1.59-2.40]). Women who were not compliant with recommendations were more likely to be older (mean age, 49.2 yrs. vs. 43.2 yrs), living alone (single, widowed or divorced, 40% vs. 30%, P < 0.05), and/or socially vulnerable (55% vs. 35%, P < 0.05; OR = 1.78, 95% CI [1.49-2.12]). Conclusion. This analysis identified several factors associated with never screening and under-screening. Effective prevention messages should specifically target these populations. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 50 条
  • [31] Factors associated with cervical cancer screening in a safety net population
    Heberer, Meredith A.
    Komenaka, Ian K.
    Nodora, Jesse N.
    Hsu, Chiu-Hsieh
    Gandhi, Sonal G.
    Welch, Lauren E.
    Bouton, Marcia E.
    Aristizabal, Paula
    Weiss, Barry D.
    Martinez, Maria Elena
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2016, 7 (05): : 406 - 413
  • [32] Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey
    Chan, Yee Mang
    Ismail, Muhd Zulfadli Hafiz
    Khaw, Wan-Fei
    BMC WOMENS HEALTH, 2023, 23 (01)
  • [33] Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey
    Yee Mang Chan
    Muhd Zulfadli Hafiz Ismail
    Wan-Fei Khaw
    BMC Women's Health, 23
  • [34] Knowledge of bladder cancer in the French population: results of the EDIFICE 6 survey
    Roupret, Morgan
    Morere, Jean-Francois
    Touboul, Chantal
    Lhomel, Christine
    Couraud, Sebastien
    Rouge, Thibault de la Motte
    EUROPEAN JOURNAL OF CANCER CARE, 2021, 30 (03)
  • [35] The cost of screening for breast and cervical cancer in France
    Wait, S
    BULLETIN DU CANCER, 2003, 90 (11) : 997 - 1004
  • [36] Organized cervical cancer screening at last in France!!
    Baldauf, J. -J.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2019, 47 (01): : 1 - 2
  • [37] New recommendations for cervical cancer screening in France
    Baraquin, A.
    Pepin, L.
    Floerchinger, P.
    Lepiller, Q.
    Pretet, J. -l.
    ANNALES PHARMACEUTIQUES FRANCAISES, 2023, 81 (02): : 202 - 209
  • [38] CANCER SCREENING IN UNDERSERVED, VULNERABLE POPULATION. RESULTS FROM THE EDIFICE SURVEY
    Eisinger, F.
    Viguier, J.
    Touboul, C.
    Coscas, Y.
    Pivot, X.
    Blay, J.
    Lhomel, C.
    Morere, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 470 - 471
  • [39] Recommended cancer screening and vulnerable populations: results from the EDIFICE 5 survey
    Morere, J-F.
    Eisinger, F.
    Blay, J-Y.
    Couraud, S.
    Brignoli-Guibaudet, L.
    Lhomel, C.
    Cortot, A.
    Greillier, L.
    Viguier, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] Less cancer screening in the vulnerable population? Results from the EDIFICE 4 survey
    Morere, J. F.
    Viguier, J.
    Greillier, L.
    Touboul, C.
    Blay, J. Y.
    Couraud, S.
    Cortot, A.
    Lhomel, C.
    Pivot, X.
    Eisinger, F.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S164 - S164